Homologous Care for Plantar Fascia Tissue Degeneration
Plantar fasciopathy is the leading cause of heel pain and often persists despite standard care. This study evaluated whether Wharton’s Jelly (WJ), a collagen-rich connective tissue allograft, can supplement damaged fascia as a conservative, homologous support option.
The goal was to assess the safety and clinical impact of applying WJ to ultrasound-confirmed plantar fascia defects in patients who had already failed months of conservative treatment.
Study Overview
- Design: Observational study within Regenative Labs’ outcomes repository, IRB-approved (IRCM)
- Participants: 9 patients (mean age 73) with ultrasound-verified plantar fascia degeneration unresponsive to ≥3 months of care
- Intervention: Single ultrasound-guided percutaneous application of a 150 mg Umbilical Cord Tissue (UCT) allograft
Clinical Significance
Study findings suggest UCT allografts may serve as a regenerative-first option before surgical intervention. By supplementing the damaged fascia with a biologically familiar matrix, these allografts support structure and function without altering anatomy.
A Step Toward Evidence-Based Regenerative Care
This publication expands Regenative Labs’ body of research supporting the homologous, tissue-specific role of Wharton’s Jelly in musculoskeletal applications.
Request Your Copy
Use the form below to request the full article:
“Umbilical Cord Tissue for Tearing in the Plantar Fascia.”